BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muir AJ. Understanding the Complexities of Cirrhosis. Clinical Therapeutics 2015;37:1822-36. [DOI: 10.1016/j.clinthera.2015.05.507] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Mun H, So ES. Prevalence of Liver Cirrhosis based on the Metabolic Health and Weight Criteria: Report from the Korea National Health and Nutritional Health Examination Survey (KNANES) Data Analysis. Annals of Hepatology 2022. [DOI: 10.1016/j.aohep.2022.100721] [Reference Citation Analysis]
2 Cross TJS. Detection of all-cause advanced hepatic fibrosis using an ensemble machine learning framework. The Lancet Digital Health 2022;4:e152-3. [DOI: 10.1016/s2589-7500(22)00026-7] [Reference Citation Analysis]
3 Aller MA, Arias N, Blanco-Rivero J, Balfagón G, Arias J. Portal hypertension: The desperate search for the placenta. Curr Res Transl Med 2019;67:56-61. [PMID: 30503816 DOI: 10.1016/j.retram.2018.09.001] [Reference Citation Analysis]
4 Shankaraiah RC, Callegari E, Guerriero P, Rimessi A, Pinton P, Gramantieri L, Silini EM, Sabbioni S, Negrini M. Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma. Oncogene 2019;38:7035-45. [PMID: 31409896 DOI: 10.1038/s41388-019-0942-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
5 Stelmach M, de Almeida Medeiros KA, Carvalho BJ, Pipek LZ, de Mesquita GHA, Nii F, Martines DR, Iuamoto LR, D'Albuquerque LAC, Meyer A, Andraus W. Instrument to evaluate the knowledge of patient with cirrhosis on his disease: construction and validity. BMC Gastroenterol 2021;21:83. [PMID: 33622249 DOI: 10.1186/s12876-021-01665-0] [Reference Citation Analysis]
6 Yao Y, Yang D, Huang Y, Dong M. Predictive value of insulin-like growth factor 1-Child-Turcotte-Pugh score for mortality in patients with decompensated cirrhosis. Clin Chim Acta 2020;505:141-7. [PMID: 32119835 DOI: 10.1016/j.cca.2020.02.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dong N, Chen WT, Bao M, Lu Y, Qian Y, Lu H. Self-Management Behaviors Among Patients With Liver Cirrhosis in Shanghai, China: A Cross-Sectional Study. Clin Nurs Res 2020;29:448-59. [PMID: 29806496 DOI: 10.1177/1054773818777914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Matthews K, Macgilchrist A, Coulter‐smith M, Jones J, Cetnarskyj R. A nurse‐led FibroScan ® outreach clinic encourages socially deprived heavy drinkers to engage with liver services. J Clin Nurs 2018;28:650-62. [DOI: 10.1111/jocn.14660] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Carbonneau M, Davyduke T, Spiers J, Brisebois A, Ismond K, Tandon P. Patient Views on Advance Care Planning in Cirrhosis: A Qualitative Analysis. Can J Gastroenterol Hepatol 2018;2018:4040518. [PMID: 30079330 DOI: 10.1155/2018/4040518] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
10 Yang JY, Moon AM, Kim H, Pate V, Barritt AS 4th, Crowley MJ, Buse JB, Stürmer T, Alexopoulos AS. Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes. J Diabetes Complications 2020;34:107706. [PMID: 32843283 DOI: 10.1016/j.jdiacomp.2020.107706] [Reference Citation Analysis]
11 Fernandes SA, Leonhardt LR, da Silva DM, Alves FD, Marroni CA. Bioelectrical impedance vector analysis evaluates cellularity and hydration in cirrhotic patients. World J Hepatol 2020; 12(12): 1276-1288 [PMID: 33442454 DOI: 10.4254/wjh.v12.i12.1276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cervantes-Garcia D, Cuellar-Juarez AG, Borrego-Soto G, Rojas-Martinez A, Aldaba-Muruato LR, Salinas E, Ventura-Juarez J, Muñoz-Ortega MH. Adenoviral‑bone morphogenetic protein‑7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model. Mol Med Rep 2017;16:9431-40. [PMID: 29039539 DOI: 10.3892/mmr.2017.7785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
13 Ferreira S, Marroni CA, Stein JT, Rayn R, Henz AC, Schmidt NP, Carteri RB, Fernandes SA. Assessment of resting energy expenditure in patients with cirrhosis. World J Hepatol 2022; 14(4): 802-811 [DOI: 10.4254/wjh.v14.i4.802] [Reference Citation Analysis]
14 Treem WR, Palmer M, Lonjon-Domanec I, Seekins D, Dimick-Santos L, Avigan MI, Marcinak JF, Dash A, Regev A, Maller E, Patwardhan M, Lewis JH, Rockey DC, Di Bisceglie AM, Freston JW, Andrade RJ, Chalasani N. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Saf 2021;44:133-65. [PMID: 33141341 DOI: 10.1007/s40264-020-01014-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Kagadis GC, Drazinos P, Gatos I, Tsantis S, Papadimitroulas P, Spiliopoulos S, Karnabatidis D, Theotokas I, Zoumpoulis P, Hazle JD. Deep learning networks on chronic liver disease assessment with fine-tuning of shear wave elastography image sequences. Phys Med Biol 2020;65:215027. [PMID: 32998480 DOI: 10.1088/1361-6560/abae06] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
16 Philips CA, Augustine P, Rajesh S, Ahamed R, George T, Padsalgi G, Paramaguru R, Valiathan G, John SK. Granulocyte Colony-Stimulating Factor Use in Decompensated Cirrhosis: Lack of Survival Benefit. J Clin Exp Hepatol 2020;10:124-34. [PMID: 32189927 DOI: 10.1016/j.jceh.2019.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
17 Poordad F, Castro RE, Asatryan A, Aguilar H, Cacoub P, Dieterich D, Marinho RT, Carvalho A, Siddique A, Hu YB, Charafeddine M, Bondin M, Khan N, Cohen DE, Felizarta F. Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials. J Viral Hepat 2020;27:497-504. [PMID: 31954087 DOI: 10.1111/jvh.13261] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Son JH, Lee SS, Lee Y, Kang BK, Sung YS, Jo S, Yu E. Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease.Eur Radiol. 2020;30:3486-3496. [PMID: 32055946 DOI: 10.1007/s00330-020-06665-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
19 Nartey YA, Asem M, Agyei-Nkansah A, Awuku YA, Setorglo J, Duah A, Bampoh S, Ayawin J, Asibey SO, Ye W, Afihene MY, Roberts L, Plymoth A. Nutritional management of cirrhosis patients: A qualitative study exploring perceptions of patients and health workers in Ghana. Clin Nutr ESPEN 2019;34:18-22. [PMID: 31677706 DOI: 10.1016/j.clnesp.2019.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Sarabia Aldana CA, Medina-torres L, Calderas F, Ramírez-torres LA, Núñez-ramírez D, Herrera-valencia EE, Bernad-bernad MJ, Manero O. Hemorheological and biochemical study in patients with liver cirrhosis. Physics of Fluids 2022;34:041907. [DOI: 10.1063/5.0086561] [Reference Citation Analysis]
21 Elhani I, Pillebout E, Terrier B, Hankard A, Vrtovsnik F, Jourde-Chiche N, Greillier S, Groh M, Belfeki N, Bigot A, de Boysson H, Pageaux GP, Raffray L, Urbanski G, Ollivier I, Maillot F, Aouba A, Audemard-Verger A; Alexandra Audemard-Verger on behalf of the French Vasculitis Study Group (FVSG) and the HSPrognosis Group. IgA Vasculitis With Underlying Liver Cirrhosis: A French Nationwide Case Series of 20 Patients. J Rheumatol 2021;48:735-40. [PMID: 32801133 DOI: 10.3899/jrheum.200293] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sarvestany SS, Kwong JC, Azhie A, Dong V, Cerocchi O, Ali AF, Karnam RS, Kuriry H, Shengir M, Candido E, Duchen R, Sebastiani G, Patel K, Goldenberg A, Bhat M. Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study. The Lancet Digital Health 2022;4:e188-99. [DOI: 10.1016/s2589-7500(21)00270-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]